VERINTEX gouttes buvables fl 50 ml

7680554440212 CH-55444 20.01.2.
VERINTEX gouttes buvables fl 50 ml
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5544401
CPT
-
Packaging group
50
Unit
ml
Composition
acidum nitricum (HAB) D8 125 mg, acidum silicicum (HAB) D12 115 mg, causticum hahnemanni (HAB) D4 140 mg, delphinium staphisagria e semine spag. Peka D6 (HAB 47b) 110 mg, ruta graveolens ex herba cum floribus spag. Peka D4 (HAB 47a) 145 mg, solanum dulcamara (HAB) D4 125 mg, stibium sulfuratum nigrum (HAB) D6 125 mg, thuja occidentalis (HAB) D12 115 mg, ethanolum 96 per centum, aqua purificata, ad solutionem pro 1 g, corresp. 1.02 ml, corresp. 30 guttae, corresp. ethanolum 18 % V/V.

Articles (1)

Verintex, Tropfen zum Einnehmen
Tropfen zum Einnehmen
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/11/2024
Patient information leaflet
Français
12/11/2024
Patient information leaflet
Italien
12/11/2024

Detailed composition

Substance Quantity Type Category
acidum nitricum (HAB)
125.0 MG Substance Wirkstoff (Principe actif)
acidum silicicum (HAB)
115.0 MG Substance Wirkstoff (Principe actif)
causticum hahnemanni (HAB)
140.0 MG Substance Wirkstoff (Principe actif)
delphinium staphisagria e semine (Staphysagria Ph.Eur.Hom.) spag. Peka
110.0 MG Substance Wirkstoff (Principe actif)
ruta graveolens ex herba cum floribus (ruta graveolens HAB) spag. Peka
145.0 MG Substance Wirkstoff (Principe actif)
solanum dulcamara (HAB)
125.0 MG Substance Wirkstoff (Principe actif)
stibium sulfuratum nigrum (HAB)
125.0 MG Substance Wirkstoff (Principe actif)
thuja occidentalis (HAB)
115.0 MG Substance Wirkstoff (Principe actif)
ethanolum 96 per centum
- Substance HBESI
aqua purificata
- Substance HNIDK

Authorization holder

ebi-pharm ag

3038 Kirchlindach

Authorization information

Swissmedic authorization number
55444
Drug name
Verintex, Tropfen zum Einnehmen
Galenic form
TROF
Authorization status
Z
Dispensation category
D
First authorization
01/09/2000
Authorization expiration date
31/12/9999
IT number
20.01.2.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild und dem Therapieprinzip der Spagyrik bei Warzen.

Packaging details

Description (FR)
VERINTEX gouttes buvables fl 50 ml
Description (DE)
VERINTEX Tropfen zum Einnehmen Fl 50 ml
Market launch
01/09/2000
Narcotic (BTM)
No
Buy us a coffee Explore the data